Skip to main content
. 2022 May 3;12(5):595. doi: 10.3390/brainsci12050595

Figure 3.

Figure 3

Salivary Aβ40, Aβ42, t-tau, p-tau, p-tau/t-tau, and Aβ42/Aβ40 in AD patients and non-AD controls. Lines represent the maximum and minimum range.